出版商更正：高危可切除黑色素瘤的新辅助免疫检查点阻断。

Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.

作者信息

Amaria Rodabe N, Reddy Sangeetha M, Tawbi Hussein A, Davies Michael A, Ross Merrick I, Glitza Isabella C, Cormier Janice N, Lewis Carol, Hwu Wen-Jen, Hanna Ehab, Diab Adi, Wong Michael K, Royal Richard, Gross Neil, Weber Randal, Lai Stephen Y, Ehlers Richard, Blando Jorge, Milton Denái R, Woodman Scott, Kageyama Robin, Wells Daniel K, Hwu Patrick, Patel Sapna P, Lucci Anthony, Hessel Amy, Lee Jeffrey E, Gershenwald Jeffrey, Simpson Lauren, Burton Elizabeth M, Posada Liberty, Haydu Lauren, Wang Linghua, Zhang Shaojun, Lazar Alexander J, Hudgens Courtney W, Gopalakrishnan Vancheswaran, Reuben Alexandre, Andrews Miles C, Spencer Christine N, Prieto Victor, Sharma Padmanee, Allison James, Tetzlaff Michael T, Wargo Jennifer A

机构信息

Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.

Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Nat Med. 2018 Dec;24(12):1942. doi: 10.1038/s41591-018-0252-y.

DOI:10.1038/s41591-018-0252-y

PMID:30361511

Abstract

In the version of this article originally published, there was an error in Fig. 1. In the neoadjuvant phase column, the n values for arms A and B were both reported to be 20. The n values for arms A and B were actually 12 and 11, respectively. Also, the URL underlying the accession code in the data availability section was incorrect. The URL was originally https://www.ebi.ac.uk/ega/studies/EGAS00001002698. It should have been https://www.ebi.ac.uk/ega/studies/EGAS00001003178. The errors have been corrected in the print, HTML and PDF versions of this article.

摘要

在本文最初发表的版本中，图1存在一处错误。在新辅助治疗阶段一栏中，A组和B组的n值均报告为20。实际上，A组和B组的n值分别为12和11。此外，数据可用性部分中登录号的相关网址有误。原网址为https://www.ebi.ac.uk/ega/studies/EGAS00001002698，应为https://www.ebi.ac.uk/ega/studies/EGAS00001003178。本文的印刷版、HTML版和PDF版中已对这些错误进行了更正。